(Q28534835)

English

Is the United States still dominant in the global pharmaceutical innovation network?

scientific article (publication date: 2013)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Is the United States still dominant in the global pharmaceutical innovation network? (English)

0 references

main subject

United States of America

0 references

Thomas Scherngell

2

0 references

author name string

Yuanjia Hu

series ordinal

1

0 references

Si Nga Man

series ordinal

3

0 references

Yitao Wang

series ordinal

4

0 references

language of work or name

English

0 references

publication date

2013

0 references

published in

PLOS One

0 references

volume

8

0 references

issue

11

0 references

page(s)

e77247

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

5 November 2013

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Multi-target drugs: the trend of drug research and development

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818371

retrieved

19 March 2017

The United States of America and scientific research

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818371

retrieved

29 September 2017

Deconstructing the drug development process: the new face of innovation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818371

retrieved

29 September 2017

US fiscal deal leaves science vulnerable

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077247

retrieved

21 January 2018

Clinical research in China and India: a paradigm shift in drug development

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24223710

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open innovation: share or die...

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24223710

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving R&D for emerging markets

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24223710

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Location of pharmaceutical innovation: 2000-2009

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24223710

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

China's drug innovation and policy environment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24223710

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0077247

0 references

0 references

0 references

PubMed publication ID

24223710

0 references

ResearchGate publication ID

258504658

0 references

(Q28534835)

Is the United States still dominant in the global pharmaceutical innovation network?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)